OpenInsiders01Web Canada
SEC INSIDER TRANSACTIONS

TRAVELERS COMPANIES, INC. (TRV) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

TRV · TRAVELERS COMPANIES, INC.

How to read this data ↗
More transaction filters

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 30 filings · fetched 2026-11-13T20:19:49Z

Recent reported activity

0purchase rows on this page
10sale rows on this page
75matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filedReporting owner(s)Code / securityQuantityPrice as filedOwnershipSource
2026-10-21Filed 2026-10-22OLIVO MARIAOfficer · EVP, ERM & Chief Risk Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents the weighted average sales price for price increments ranging from $398.35 to $398.62. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.

References: F1

S Sale (market/private)Common Stock · Non-derivative15,100D398.4441DirectForm 4 ↗0000086312-26-000184
2026-10-20Filed 2026-10-22Klein Michael FrederickOfficer · EVP & President, Personal Ins.
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents the weighted average sales price for price increments ranging from $392.170 to $393.165. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2 Represents the weighted average sales price for price increments ranging from $393.170 to $393.315. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

References:

M Exercise / conversionStock Options (Right to Buy) · Derivative7,500D0DirectForm 4 ↗0000086312-26-000183
2026-10-20Filed 2026-10-22Klein Michael FrederickOfficer · EVP & President, Personal Ins.
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents the weighted average sales price for price increments ranging from $392.170 to $393.165. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2 Represents the weighted average sales price for price increments ranging from $393.170 to $393.315. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

References: F2

S Sale (market/private)Common Stock · Non-derivative1,359D393.2592DirectForm 4 ↗0000086312-26-000183
2026-10-20Filed 2026-10-22Klein Michael FrederickOfficer · EVP & President, Personal Ins.
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents the weighted average sales price for price increments ranging from $392.170 to $393.165. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2 Represents the weighted average sales price for price increments ranging from $393.170 to $393.315. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

References: F1

S Sale (market/private)Common Stock · Non-derivative6,141D392.6874DirectForm 4 ↗0000086312-26-000183
2026-10-20Filed 2026-10-22Klein Michael FrederickOfficer · EVP & President, Personal Ins.
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents the weighted average sales price for price increments ranging from $392.170 to $393.165. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2 Represents the weighted average sales price for price increments ranging from $393.170 to $393.315. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

References:

M Exercise / conversionCommon Stock · Non-derivative7,500A139.83DirectForm 4 ↗0000086312-26-000183
2026-09-30Filed 2026-10-01Robinson ElizabethDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These are deferred common stock units received in lieu of cash compensation pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. The deferred common stock units will be converted into shares of Company common stock on a one-for-one basis upon distribution. Distribution of shares of common stock occurs, at the election of the director, either in a lump sum or in annual installments pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors.

F2 Includes the deferred common stock units granted under one or more of the Company's directors' compensation plans. Also includes 44.05 deferred common stock units acquired on September 30, 2026 pursuant to the dividend reinvestment features of those plans, which will be distributed as described in footnote 1 above.

References: F1, F2

A Award / grantCommon Stock · Non-derivative122.72A356.51DirectForm 4 ↗0000086312-26-000172
2026-09-30Filed 2026-10-01Jabbour Anthony MDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These are deferred common stock units received in lieu of cash compensation pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. The deferred common stock units will be converted into shares of Company common stock on a one-for-one basis upon distribution. Distribution of shares of common stock occurs, at the election of the director, either in a lump sum or in annual installments pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors.

F2 Includes the deferred common stock units granted under one or more of the Company's directors' compensation plans. Also includes 1.564 deferred common stock units acquired on September 30, 2026 pursuant to the dividend reinvestment features of those plans, which will be distributed as described in footnote 1 above.

References: F1, F2

A Award / grantCommon Stock · Non-derivative65.17A356.51DirectForm 4 ↗0000086312-26-000170
2026-09-30Filed 2026-10-01Golden Russell G.Director
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 These are deferred common stock units received in lieu of cash compensation pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors. The deferred common stock units will be converted into shares of Company common stock on a one-for-one basis upon distribution. Distribution of shares of common stock occurs, at the election of the director, either in a lump sum or in annual installments pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors.

F2 Includes the deferred common stock units granted under one or more of the Company's directors' compensation plans. Also includes 19.634 deferred common stock units acquired on September 30, 2026 pursuant to the dividend reinvestment features of those plans, which will be distributed as described in footnote 1 above.

References: F1, F2

A Award / grantCommon Stock · Non-derivative129.73A356.51DirectForm 4 ↗0000086312-26-000168
2026-08-28Filed 2026-08-31OLIVO MARIAOfficer · EVP, ERM & Chief Risk Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents the weighted average sales price for price increments ranging from $369.81 to $369.962. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.

References: F1

S Sale (market/private)Common Stock · Non-derivative6,000D369.8575DirectForm 4 ↗0000086312-26-000166
2026-08-14Filed 2026-08-18Jabbour Anthony MDirector
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Consists of deferred stock units awarded pursuant to the Company's Amended and Restated 2023 Stock Incentive Plan and the Deferred Compensation Plan for Non-Employee Directors. The deferred stock units will be converted into shares of Company common stock on a one-for-one basis upon distribution. Distribution of shares of common stock occurs, at the election of the director, either in a lump sum or in annual installments beginning at least six months following termination of his or her service as a director pursuant to the Company's Deferred Compensation Plan for Non-Employee Directors.

References: F1

A Award / grantCommon Stock · Non-derivative446A370.36DirectForm 4 ↗0000086312-26-000165
2026-07-24Filed 2026-07-27Yin Daniel Tei-HwaOfficer · EVP & Co-Chief Invest. Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

References:

M Exercise / conversionStock Options (Right to Buy) · Derivative7,153D0DirectForm 4 ↗0000086312-26-000158
2026-07-24Filed 2026-07-27Yin Daniel Tei-HwaOfficer · EVP & Co-Chief Invest. Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

References:

S Sale (market/private)Common Stock · Non-derivative7,153D387DirectForm 4 ↗0000086312-26-000158
2026-07-24Filed 2026-07-27Yin Daniel Tei-HwaOfficer · EVP & Co-Chief Invest. Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

References:

M Exercise / conversionCommon Stock · Non-derivative7,153A140.85DirectForm 4 ↗0000086312-26-000158
2026-07-24Filed 2026-07-27Kurtzman DianeOfficer · EVP & Chief HR Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

References:

M Exercise / conversionStock Options (Right to Buy) · Derivative4,164D0DirectForm 4 ↗0000086312-26-000157
2026-07-24Filed 2026-07-27Kurtzman DianeOfficer · EVP & Chief HR Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

References:

S Sale (market/private)Common Stock · Non-derivative4,164D386.71DirectForm 4 ↗0000086312-26-000157
2026-07-24Filed 2026-07-27Kurtzman DianeOfficer · EVP & Chief HR Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

References:

M Exercise / conversionCommon Stock · Non-derivative4,164A132.58DirectForm 4 ↗0000086312-26-000157
2026-07-22Filed 2026-07-24Rowland David DonnayOfficer · EVP & Co-Chief Invest. Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

References:

M Exercise / conversionStock Options (Right to Buy) · Derivative5,000D0DirectForm 4 ↗0000086312-26-000156
2026-07-22Filed 2026-07-24Rowland David DonnayOfficer · EVP & Co-Chief Invest. Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

References:

S Sale (market/private)Common Stock · Non-derivative5,000D371.688DirectForm 4 ↗0000086312-26-000156
2026-07-22Filed 2026-07-24Rowland David DonnayOfficer · EVP & Co-Chief Invest. Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

References:

M Exercise / conversionCommon Stock · Non-derivative5,000A132.58DirectForm 4 ↗0000086312-26-000156
2026-07-22Filed 2026-07-24Munson Paul E.Officer · SVP & Corp. Controller
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

References:

M Exercise / conversionStock Options (Right to Buy) · Derivative1,525D0DirectForm 4 ↗0000086312-26-000154
2026-07-22Filed 2026-07-24Munson Paul E.Officer · SVP & Corp. Controller
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

References:

S Sale (market/private)Common Stock · Non-derivative1,525D369.905DirectForm 4 ↗0000086312-26-000154
2026-07-22Filed 2026-07-24Munson Paul E.Officer · SVP & Corp. Controller
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

References:

M Exercise / conversionCommon Stock · Non-derivative1,525A126.18DirectForm 4 ↗0000086312-26-000154
2026-07-22Filed 2026-07-24BESSETTE ANDY FOfficer · EVP and Chief Admin Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents the weighted average sales price for price increments ranging from $367.86 to $368.84. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

References:

S Sale (market/private)Common Stock · Non-derivative100D368.865DirectForm 4 ↗0000086312-26-000152
2026-07-22Filed 2026-07-24BESSETTE ANDY FOfficer · EVP and Chief Admin Officer
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents the weighted average sales price for price increments ranging from $367.86 to $368.84. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

References: F1

S Sale (market/private)Common Stock · Non-derivative2,900D368.0865DirectForm 4 ↗0000086312-26-000152
2026-07-21Filed 2026-07-23Klein Michael FrederickOfficer · EVP & President, Personal Ins.
Filing context

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents the weighted average sales price for price increments ranging from $364.72 to $365.03. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2 Represents the weighted average sales price for price increments ranging from $365.798 to $366.275. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

References:

M Exercise / conversionStock Options (Right to Buy) · Derivative6,000D0DirectForm 4 ↗0000086312-26-000150

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.